Directed share issue in BioGaia AB (SE) — SEK 1.1 billion

Carnegie acted as sole global co-ordinator and sole bookrunner in the directed share issue of 2.85 million new class B shares at a subscription price of SEK 400 per share. BioGaia is an innovative Swedish healthcare company that develops, markets and sells probiotic products with documented health benefits. November 2020.